Trial
NCT02372240
A Study of VLX1570 and Dexamethasone in Myeloma Patients
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Vivolux AB
Collaborators
Theradex
Condition
Multiple Myeloma
Intervention
VLX1570 and dexamethasone
Why stopped
Dose limiting tox is observed. Study put on full clinical hold.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-11